Moderna sign production deal with South Korea's Samsung Biologics

(Reuters) -Moderna Inc said on Saturday it has entered into an agreement with Samsung Biologics Co Ltd , a deal which will allow the South Korean biopharmaceutical firm to produce the U.S. company's mRNA vaccine. Moderna intends to supply these vaccines to markets outside of the United States starting in...